This invention comprises compositions containing dihydroartemisinin and
dihydroartemisitene dimers with activity as anticancer agents and
anti-protozal, including anti-malarial and anti-leishmanial properties.
This invention also describes methods of preparation of these compositions
and methods of use of such compositions for the treatment of cancer, and
protozoal infections, including malaria, or leishmaniasis. The compounds
of this invention represent a potential new class of anti-tumor agents,
one that has shown promising activity against solid tumors, and with a
pattern of selectivity that suggests a possible new mechanism of action.
